September 22, 2011
TerpeneTech Limited, on September 22, 2011, entered into exclusive worldwide licensing and marketing agreements with Eden Research Plc for the use of Eden’s patented yeast particle microencapsulation technology in the fields of Consumer and Agro-industry Biocide Products.
TerpeneTech was also granted access to Eden’s Dossier Data relating to Geraniol, Eugenol and Thymol for the purpose of selling both encapsulated and un-encapsulated Terpene based products.
May 20, 2013
On May 20, 2013 Eden Research Plc. Announced that the three active substance dossiers were approved for use in plant protection products by the European Commission (“EC”) under Regulation (EC) No. 1107/2009 within the European Union for Annex I inclusion.
December 1st, 2015
On December 1st, 2015, TerpeneTech was identified as Active Substance Supplier for Geraniol CAS-106-24-1) for its use in Insecticides (PT19) and Repellents (PT18). ECHA granted TerpeneTech the legal right to supply Geraniol to the EU market as a Biocide Active Substance and provide Letters of Access to support its customer product registrations.
October 6th 2018
After 3 years of R&D and Regulatory work, On October 6th 2018, TerpeneTech submitted a Medical Device Manufacturer Notification for its Head Lice Lotion to the MHRA.
To insure against Brexit, protect its clients and maintain its rights as an EU Biocide Active Substance Supplier and as a Medical Device Manufacturer, TerpeneTech established TerpeneTech Ireland to hold its EU registrations.